The Paxlovid pills are being developed at Pfizer’s two Irish plants in Ringaskiddy and Newbridge. Picture: Reuters
Pfizer’s new anti-viral drugs for Covid-19 will only be prescribed for “high-risk patients” for now, but may provide benefits to the wider public in time, according to the scientist who developed the treatment. Dr Annaliesa Anderson, the clinical development lead on the Paxlovid antiviral programme, was speaking to the Business Post from New Jersey in the US.Subscribe from just €1 for the first month!
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
New bill may push more legal costs on those who take insurers to court | Business PostRobert Troy: ‘If someone wants to reject their award and bring it to court and the court doesn’t increase the award any further, well then, they're going to have to pay for that’ obraonain now this is a good thing and will help
Herkunft: businessposthq - 🏆 8. / 71 Weiterlesen »
Ronan to make new play for Dublin portfolio after legal case dropped | Business PostDeveloper may be seeking a new partner to bid for three landmark properties after ongoing dispute with US group Fortress is resolved out of court
Herkunft: businessposthq - 🏆 8. / 71 Weiterlesen »
ESB’s new gas power contracts triple in value | Business PostWhistleblower has accused semi-state of abusing market position and ‘lowballing’ offers in earlier auctions
Herkunft: businessposthq - 🏆 8. / 71 Weiterlesen »